View of 06 | Nirsevimab as a key strategy to prevent respiratory syncytial virus among newborns and children: real-world evidence from Italy and Sicily

Return to Issue Details 06 | Nirsevimab as a key strategy to prevent respiratory syncytial virus among newborns and children: real-world evidence from Italy and Sicily Download Download PDF